No Data
Yixintang Pharmaceutical (002727.SZ): Sichuan Yixintang plans to invest 0.368 billion yuan to construct the large health intelligent pharmaceutical base logistics center project.
On November 26, Gelonghui reported that yixintang pharmaceutical (002727.SZ) announced that, according to the company's global strategy and business positioning, to enhance the company's logistics delivery capacity within Sichuan Province and meet future development needs, the company has agreed that its wholly-owned subsidiary yixintang pharmaceutical (Sichuan) Co., Ltd. (hereinafter referred to as "Sichuan yixintang") will invest 0.368 billion yuan to construct a logistics center project for the health and intelligent pharmaceutical base in Chengdu, Sichuan Province. The new logistics center is expected to meet the business development needs of the company in the Sichuan-Chongqing region.
Universal Health International Unit Buys Stake in Hollow Capsule Manufacturer
Uni health (02211.HK) plans to sell a 43.78% stake in jilin Jintian Uni Health Group for 43 million yuan.
Grain Hall November 19th | Uni Health International (02211.HK) announced that on November 19, 2024, the seller (Heilongjiang Jintian Love Pharmaceutical Distribution Co., Ltd.) (an indirect wholly-owned subsidiary of the company), entered into an equity transfer agreement with the buyer (Huang Yanling). According to this, the seller has conditionally agreed to sell, and the buyer has conditionally agreed to acquire 43.78% equity of Jilin Jintian Uni Health Capsule Co., Ltd., for RMB 43 million, subject to the restrictions of the equity transfer agreement. After the completion of the sale, the company will no longer hold any equity in the target company. Target Public
Express News | Universal Health International - Unit to Sell 43.78% Stake in Jilin Jintian Universal Health Group Capsules for RMB43.0 Mln
Guizhou Yibai Pharmaceutical (600594.SH): Currently, the company's focus on health products is mainly on throat lozenges, instant beverages, and solid beverages.
Gelonghui November 11th | Guizhou Yibai Pharmaceutical (600594.SH) expressed on the investor interaction platform that the company currently has anti-tumor products such as injection L-OHP, Kangsaidi capsules, and Aiyu capsules. Currently, the company's health products are mainly focused on throat lozenges, instant drinks, solid beverages, etc.
tianjin ringpu bio-technology (300119.SZ) is planning to acquire 15% equity of Zhong Rui Huapu to improve its strategic layout in the pet health sector.
Zhijian Financial APP news, tianjin ringpu bio-technology (300119.SZ) issued an announcement, to continue to improve the company's strategic layout in the pet health sector...
No Data
No Data